Pseudobulbar Affect in Parkinsonian Disorders: A Review

被引:12
|
作者
Hakimi, Mathew [1 ]
Maurer, Carine W. [2 ]
机构
[1] SUNY Stony Brook, Sch Med, Stony Brook, NY 11794 USA
[2] SUNY Stony Brook, Sch Med, Dept Neurol, Stony Brook, NY 11794 USA
关键词
Pseudobulbar affect; Parkinson's disease; parkinsonism; PATHOLOGICAL LAUGHTER; DEXTROMETHORPHAN/QUINIDINE; STIMULATION; VALIDATION; FREQUENCY; QUINIDINE; DISEASE; REGION; SCALE; MOOD;
D O I
10.14802/jmd.18051
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Pseudobulbar affect (PBA) is a neurological symptom of inappropriate and uncontrollable laughter or crying that occurs secondary to a variety of neurological conditions, including parkinsonian disorders. PBA is a socially and emotionally debilitating symptom that has been estimated to affect 3.6% to 42.5% of the population with Parkinson's disease. While indexing measures and treatment options for PBA have been extensively studied in neurological conditions such as amyotrophic lateral sclerosis and multiple sclerosis, there has been considerably less attention given in the literature to PBA in parkinsonian disorders. The purpose of this review is to discuss the pathophysiology of PBA, its prevalence and impact on quality of life in parkinsonian disorders, and the treatment options currently available. Areas requiring further study, including the development of standardized, cross-culturally validated methods of symptom assessment, and evidence-based studies exploring the efficacy of current treatment options in parkinsonian disorders, are also highlighted.
引用
收藏
页码:14 / 21
页数:8
相关论文
共 50 条
  • [21] Impaired corticopontocerebellar tracts underlie pseudobulbar affect in motor neuron disorders
    Floeter, Mary Kay
    Katipally, Rohan
    Kim, Meredith P.
    Schanz, Olivia
    Stephen, Matthew
    Danielian, Laura
    Wu, Tianxia
    Huey, Edward D.
    Meoded, Avner
    NEUROLOGY, 2014, 83 (07) : 620 - 627
  • [22] Dextromethorphan/Quinidine: A Review of Its Use in Adults with Pseudobulbar Affect
    Yang, Lily P. H.
    Deeks, Emma D.
    DRUGS, 2015, 75 (01) : 83 - 90
  • [23] Dextromethorphan/Quinidine: A Review of Its Use in Adults with Pseudobulbar Affect
    Lily P. H. Yang
    Emma D. Deeks
    Drugs, 2015, 75 : 83 - 90
  • [24] Pharmacotherapeutic Management of Pseudobulbar Affect
    Chen, Jack J.
    AMERICAN JOURNAL OF MANAGED CARE, 2017, 23 (18) : S345 - S350
  • [25] NueDexta: A Treatment for Pseudobulbar Affect
    Roman, Marian W.
    ISSUES IN MENTAL HEALTH NURSING, 2015, 36 (12) : 1019 - 1021
  • [26] Dextromethorphan/QuinidineIn Pseudobulbar Affect
    Karly P. Garnock-Jones
    CNS Drugs, 2011, 25 : 435 - 445
  • [27] Memantine may affect pseudobulbar affect in patients with Alzheimer's disease
    Prokselj, Tatjana
    Jerin, Ales
    Kogoj, Ales
    ACTA NEUROPSYCHIATRICA, 2013, 25 (06): : 361 - 366
  • [28] Pseudobulbar Affect Presenting as Hypomania
    Espiridion, Eduardo D.
    Mitchell, Cassandra
    Kadakia, Shreeja
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2020, 12 (03)
  • [29] Use of Compounded Dextromethorphan-Quinidine Suspension for Pseudobulbar Affect in Hospice Patients
    Wahler, Robert G., Jr.
    Reiman, Alfred T.
    Schrader, Joshua V.
    JOURNAL OF PALLIATIVE MEDICINE, 2017, 20 (03) : 294 - 297
  • [30] Dextromethorphan/quinidine for pseudobulbar affect associated with subarachnoid hemorrhage
    Campbell, Kendra
    Viswanathan, Ramaswamy
    Saunders, Ramotse
    FUTURE NEUROLOGY, 2014, 9 (03) : 295 - 300